The patient should have a right to be an early adopter if he wants to. Besides, drugs will never leave alpha status if we never let them flow on the market. Alt

The patient should have a right to be an early adopter if he wants to. Besides, drugs will never leave alpha status if we never let them flow on the market. Although yes obviously a gradually titrated A/B testing scheme would be much more reasonable than the current illegal/legal shift. Moreover cf my other comments, anonymised statistics are needed.